Investigating ways to improve pain management and drug formulation.
Official title: FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS
Funded at Albany Molecular Research, INC. · NIH-11091392 · Data updated 2026-11-12
This study is all about finding better ways to manage pain by creating new and improved medications, and it’s designed for patients who are looking for effective pain relief options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | July 7, 2022 |
| Project end | July 6, 2027 |
| Funding year | 2024 |
| Award (this year) | $89,686 |
| NIH project number | 271201500005I-P00001-759502200001-1 |
| Project ID | NIH-11091392 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals experiencing chronic pain who are seeking new treatment options.
✕Less likely to help
Patients with acute pain conditions or those not interested in participating in clinical trials may not benefit from this research.
What this research studies
This research focuses on enhancing the understanding of pain and improving clinical pain management through the development of better drug formulations and manufacturing processes. It is part of the NIH's HEAL initiative, which aims to find effective solutions for pain relief. The approach includes conducting feasibility studies and ensuring clinical trial readiness, which involves preparing high-quality materials for testing new pain medications. Patients may be involved in trials that assess the effectiveness of these new formulations in managing pain.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management options for patients suffering from chronic pain.
How similar studies have gone: Previous research under the HEAL initiative has shown promise in developing new pain management strategies, indicating a potential for success in this area.
Where this research is happening
-
Albany Molecular Research, INC.
Albany, United States Active
Researchers
- Principal investigator: Allard, Melissa — Albany Molecular Research, INC.
- Study coordinator: Allard, Melissa
Related research
Other NIH-funded projects on the same topics.
-
Mediterranean low-glycemic diet to protect vision in early AMD
This project will test whether people with early age-related macular degeneration can switch to a Mediterranean-style, low-glycemic diet and whether that change might help slow vision loss.
-
Investigating a Mediterranean diet to slow vision loss in older adults with AMD
This study is looking at whether following a Mediterranean diet can help slow down vision loss from age-related macular degeneration (AMD) in people over 55 who don’t have diabetes and are in the early stages of the condition.
-
Improving pain management and treatment through clinical trial readiness and drug formulation.
This study is all about finding better ways to manage pain, so if you're dealing with pain, this research could lead to new treatments that might help you feel better.
-
Automated ABPI for Peripheral Artery Disease: A Pilot Look at Two Devices
This pilot checks if two automated ankle-brachial pressure index devices can reliably detect PAD across symptom levels and after bypass surgery, using patient and clinician feedback for practicality.
-
AI-powered personalized exercise plan for older adults using a wearable app
A wearable-enabled, AI-driven exercise app is tested to see if it’s feasible and acceptable for adults 65+ and whether it can help increase activity, improve mood, and boost quality of life.
-
Behavioral program to help depressed nursing home residents see if it helps
This study tests the InSTILL program to see if it is feasible, satisfactory, and helpful for residents of skilled nursing facilities who have depressive symptoms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.